Robert I. Haddad, Makoto Tahara, Paolo Bossi, Nicholas Ramscar, Hamza Khan, Micki Hill, Steven Pattishall, Gary Carlson, Arindam Dhar, Lillian L. Siu. "Safety and efficacy of dostarlimab monotherapy as first-line treatment in programmed cell death-ligand 1–positive recurrent/metastatic head and neck squamous cell carcinoma: Results from a phase 2 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6037